making-pharmacy-first-work-need-further-innovation Patients Related Topics 
pharmaphorum
DECEMBER 18, 2022
We live in unprecedented times, where innovation in biosciences continues to accelerate. Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. Why current patient access solutions have come up short. Yet, the healthcare experience is antiquated.
pharmaphorum
JUNE 30, 2022
At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally. Patient journey. Patient access.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarivate
APRIL 18, 2024
While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare.
European Pharmaceutical Review
MARCH 2, 2023
However, a good many companies are not yet well set up for this, leaving work still to do. The aim with the EU developments is to harmonise and streamline processes across the diverse region, making it a less daunting location for conducting clinical trials. Data lies at the heart of many of the proposed solutions.
Pharmaceutical Technology
JANUARY 20, 2023
However, during the Covid-19 pandemic, the US-based biotech rose to prominence as it was one of the first companies to develop Covid-19 vaccines with its mRNA technology. In a January business update , the company predicted it will make a minimum of $5 billion in new vaccine sales. In 2021, Moderna had a net income of $12.2
pharmaphorum
JANUARY 24, 2023
In 2023, pharmaceutical companies must unlearn the old lessons of commercial engagement, where frequency and face-to-face were key, and focus on the quality of meaningful interaction, where a healthcare professional’s attention is fully engaged and the experience is meaningful to their work.
European Pharmaceutical Review
JUNE 24, 2022
2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review. One of the key priorities of the EU’s strategy is to encourage innovation to solve unmet medical needs.
Expert insights. Personalized for you.
85 
Let's personalize your content